Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials.

"Conflicts of Interest The authors declare no conflict of interest. H.E.D.L. is a co-inventor on patents assigned to and managed by the University of California, Stanford University, and Bradford University and receives materials from MegaPro Biomedical Co. Ltd. (Zhubai City, Taiwan). L.E.D. is a compensated employee of StemMed Ltd. (Houston, TX, USA) and receives royalty income from StemMed Ltd. M.T.L. is a founder and limited partner in StemMed Ltd., a manager in StemMed Holdings, its general partner, and receives royalty income from StemMed Ltd. He is a founder and equity stakeholder in Tvardi Therapeutics, Inc. (Houston, TX, USA). S.L. has received license fees from Inotiv, Inc. (West Lafayette, IN, USA). G.L. has received research materials from Spexis. C.X.M. reports relationships with Agendia, AstraZeneca Pharm., Athenex, Bayer Healthcare Pharm., Eli Lilly and Comp. (Indianapolis, IN, USA), Guardant Health, Novartis Pharma AG, Olaris Inc. (Framingham, MA, USA), Pfizer Inc., Plus One Health GmbH, Sanofi-Genzyme, Seattle Genetics Inc. (Bothell, WA, USA), Tempus, and Wolters Kluwer. Y.M.M. has received research funding and pembrolizumab through institutional funding from Merck. R.LW. serves on the scientific advisory board of Clarity Pharmaceuticals, is a consultant, and receives stock options; is the clinical advisory board chair of Voximetry and receives stock options; and serves on scientific advisory boards and consults for BMS, Jubilant Draximage, Radiopharm, Siemens, Bayer, White Rabbit AI, and ITM."

"This research was funded by NIH: U24CA253377 (D.M.P., J.K., R.S.), P41EB013598 (D.M.P., J.K., R.S.), RO1CA215694 (J.K.), R35CA197701 (B.D.R.), U24CA237683 (B.D.R., G.D.L., T.L.C., M.T.), R01CA238023 (B.D.R., G.D.L., M.T.), U24CA231858 (R.Z., M.R., P.O.D.), U24CA264044 (P.E.K., A.M.H.), P50CA228944 (P.E.K., A.M.H.), U24CA220245 (Y.M.M., C.T.B.), U24CA226110 (M.T.L.), U24CA264298 (H.E.D-L.), U24CA209837 (K.I.S., S.L., R.L.W., L.D., C.X.M), U24CA253531 (K.I.S., S.L., R.L.W., C.X.M., L.D.), R01CA273194 (K.I.S., C.X.M), P50CA236733 (H.C.M.), U24CA220325 (H.C.M.), and 5P30CA125123 (M.T.L.); and by the Cancer Prevention Research Institute of Texas (CPRIT): RP220646 (M.T.L.)."